FDMT: 4dmoleculartherapeutics.com Narxning foydaga nisbati

4D Molecular Corp (FDMT) tovar belgisi

4D Molecular Therapeutics akademik madaniyat doirasidagi aksiyalar opsionlari tizimi va saxovatli tadqiqot moliyalashtirishi orqali yetakchi genetiklarni jalb qilmoqda. Joriy aksiya narxining ushbu grafigi -3.40 miqdoridagi P/E koeffitsiyentini ko'rsatadi. Biznes dori vositalarini yurak va ko'zlarga maqsadli yetkazib berish uchun aniq virusli kapsidlarni yaratishga tayanadi, noyob vektorlarning patent himoyasi esa raqobatchilar tomonidan narxlarga bo'lgan bosimni bartaraf etadi.

FDMT - 4D Molecular Therapeutics Narxning foydaga nisbati 04.07.2022 - 16.11.2026 oraligʻida

4dmoleculartherapeutics.com (FDMT) kompaniyasining tahliliy kesimlari

Kompaniyaning jamlanma tahlili:4DMT
4D Molecular Therapeutics asosiy tovari

4D Molecular Therapeutics gen terapiyasi uchun aniq vektorlarni ishlab chiqib, yuqori texnologiyali biofarmatsevtika nishasini egallagan. Kompaniyaning P/E trayektoriyasini tahlil qilish orqali investor bozor qiymatining sof foydaga nisbatini baholaydi. Ushbu metrika aktivning bozor shoklariga chidamliligini ko'rsatuvchi indikator bo'lib, adolatli qiymat va vahima bilan sotish o'rtasidagi chegara nuqtasini belgilaydi. "Snaipersiz" gen yetkazib berish ko'rinishidagi texnologik ustunlik uzoq muddatli pozitsiyalarni saqlab qolish uchun fundamental asosni ta'minlaydi.

Raqobatdosh kompaniyalar tahlili

tempus.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori QGEN|Biznesning o‘zini qoplash muddati Isis Pharmaceuticals|P/E multiplikatori RGEN (repligen.com)|Bozor narxining sof foydaga nisbati RNA (Avidity Biosciences, Inc.)|CRSP - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati WGS (GeneDx)|RARE: P/E multiplikatori|Beam Therapeutics Corp - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti SRPT|twistbioscience.com (TWST) - Biznesning o‘zini qoplash muddati|P/E multiplikatori TXG|NTLA (Intellia) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Stoke STOK|BioLife (BLFS) - Kapitalizatsiyaning foydaga nisbati|wavelifesciences.com - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati MAZE|SION: P/E multiplikatori|PRME - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti TSHA|QURE - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|P/E multiplikatori MGTX|Biznesning o‘zini qoplash muddati regenxbio.com|P/E multiplikatori SLDB (Solid Biosciences Inc)|OCGN: Narx-foyda multiplikatori|PACB - Narxning foydaga nisbati|Benitec (BNTC) - Narx-foyda koeffitsiyenti|DSGN: P/E multiplikatori|RCKT: Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati Lexeo Therapeutics, Inc.|Kapitalizatsiyaning foydaga nisbati Korro Bio, Inc. KRRO|P/E multiplikatori EDIT|Biznesning o‘zini qoplash muddati Silence Therapeutics Corp|Narxning foydaga nisbati proqr.com PRQR|CDXS - Narx-foyda koeffitsiyenti|SGMO - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Nautilus Biotechnology, Inc. (NAUT)|MGX: P/E multiplikatori|Narx-foyda multiplikatori DTIL|GBIO (Generation Bio) - P/E multiplikatori|Narx-foyda multiplikatori BOLD (boundlessbio.com)|Narx-foyda koeffitsiyenti XCUR (exicuretx.com)|Celsion Corporation - Narx-foyda multiplikatori|P/E multiplikatori PHIO (phiopharma.com)|P/E multiplikatori Mustang Bio, Inc. MBIO|RNAZ: Narx-foyda koeffitsiyenti|BNGO (Bionano Genomics) - Narx-foyda multiplikatori|APDN: P/E multiplikatori|bluebird bio (BLUE) - P/E multiplikatori|Narxning foydaga nisbati ImmunoPrecise Antibodies Ltd.|Kapitalizatsiyaning foydaga nisbati Omega OMGA|P/E multiplikatori OMIC|RGLS - Kapitalizatsiyaning foydaga nisbati|Syros Pharmaceuticals, Inc - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Codex DNA (TBIO)|TCON - Narxning foydaga nisbati|UBX: Narxning foydaga nisbati